543207 — Natural Biocon (India) Cashflow Statement
0.000.00%
- IN₹323.32m
- IN₹325.70m
- IN₹83.48m
- 32
- 16
- 54
- 22
Annual cashflow statement for Natural Biocon (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 0.037 | 0.879 | 2.47 | 2.25 | 0.596 |
Depreciation | |||||
Non-Cash Items | — | — | 0 | 0 | -0.11 |
Other Non-Cash Items | |||||
Changes in Working Capital | 3.21 | 1.06 | -0.366 | -3.5 | 2.46 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 3.24 | 1.94 | 2.1 | -1.25 | 2.95 |
Capital Expenditures | — | 0 | 0 | 0 | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | 0 | 0 | 0 | -201 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | — | 0 | 0 | 0 | -201 |
Financing Cash Flow Items | — | 0 | 0 | 0 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -3.22 | -1.54 | -0.186 | -0.885 | 197 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.025 | 0.398 | 1.92 | -2.13 | -1.43 |